COMPANY

Allurion Technologies

Keywords: metabolic obesity

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $5M (Form D filed Nov 26, 2025). SEC Form D 0001964979-25-000003 (Nov 26, 2025)
Evidence (1 event)
- Nov 26, 2025 · SEC Form D 0001964979-25-000003
  Name of Issuer: ALLURION TECHNOLOGIES, INC.; CIK: 1964979; Address: Natick, MA; Submission type: D; Filing date: 2025-11-26; Industry Group: Other Health Care; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 5000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Feb 20, 2026 FDA FDA PMA approval: Allurion Gastric Balloon System — P250023, Feb 20, 2026. Applicant at approval: Allurion Technologies, Inc. source ↗
Jan 14, 2025 Raise Private placement: $2.5M (total, as published), announced Jan 14, 2025. Source: SEC filing. source ↗

Raised: $2.5M. Last 2 years.

Jan 14, 2025 Private placement: $2.5M (total, as published), announced Jan 14, 2025. Source: SEC filing. source ↗

Feb 20, 2026 FDA PMA approval: Allurion Gastric Balloon System — P250023, Feb 20, 2026. Applicant at approval: Allurion Technologies, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12